Clinical factors that may confound the assessment of drug efficacy
- PMID: 1775593
Clinical factors that may confound the assessment of drug efficacy
Abstract
The development of new chemical classes of psychotherapeutic drugs offers the potential for new patterns of drug efficacy as well as decreases in side effects. However, the determination of drug efficacy can be confounded by sample selection and outcome determination factors. The ability of selected clinical factors of both types to affect the outcome of antipsychotic drug trials is reviewed. Suggestions for future clinical drug trials are made.
Similar articles
-
[Development of antituberculous drugs: current status and future prospects].Kekkaku. 2006 Dec;81(12):753-74. Kekkaku. 2006. PMID: 17240921 Review. Japanese.
-
Some problems in the conduct of psychotropic drug trials (a review).J Postgrad Med. 1983 Apr;29(2):67-74. J Postgrad Med. 1983. PMID: 6631765 No abstract available.
-
[Rater-specific interference factors in clinical trials (author's transl)].Pharmakopsychiatr Neuropsychopharmakol. 1977 May;10(3):152-62. doi: 10.1055/s-0028-1094534. Pharmakopsychiatr Neuropsychopharmakol. 1977. PMID: 360240 Clinical Trial. German. No abstract available.
-
Challenges in medication clinical trials.Psychopharmacol Bull. 1993;29(1):35-44. Psychopharmacol Bull. 1993. PMID: 8378510 Review.
-
[Clinical trials of drugs. Special features of clinical studies of analgesics and psychotropic drugs].Med Monatsschr Pharm. 2003 Jul;26(7):224-6. Med Monatsschr Pharm. 2003. PMID: 12879619 German. No abstract available.
Cited by
-
Optimising the economic efficiency of drug studies.Pharmacoeconomics. 1992 Nov;2(5):371-87. doi: 10.2165/00019053-199202050-00005. Pharmacoeconomics. 1992. PMID: 10147050 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical